Key result
17beta-estradiol (1 nm) rapidly reduced K(ATP) channel activity by 60% in wild-type mouse pancreatic beta-cells, an effect involving estrogen receptor beta and the atrial natriuretic peptide receptor.
17beta-estradiol rapidly inhibits K(ATP) channel activity and enhances insulin release in pancreatic beta-cells via an ERbeta and atrial natriuretic peptide receptor-dependent mechanism.
May inform estrogen effects on insulin secretion; leaves open translation to human physiology or therapy.
The ATP-sensitive potassium (K(ATP)) channel is a key molecule involved in glucose-stimulated insulin secretion. The activity of this channel regulates beta-cell membrane potential, glucose- induced [Ca(2+)](i) signals, and insulin release. In this study, the rapid effect of physiological concentrations of 17beta-estradiol (E2) on K(ATP) channel activity was studied in intact beta-cells by use of the patch-clamp technique. When cells from wild-type (WT) mice were used, 1 nm E2 rapidly reduced K(ATP) channel activity by 60%. The action of E2 on K(ATP) channel was not modified in beta-cells from ERalpha-/- mice, yet it was significantly reduced in cells from ERbeta-/- mice. The effect of E2 was mimicked by the ERbeta agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN). Activation of ERbeta by DPN enhanced glucose-induced Ca(2+) signals and insulin release. Previous evidence indicated that the acute inhibitory effects of E2 on K(ATP) channel activity involve cyclic GMP and cyclic GMP-dependent protein kinase. In this study, we used beta-cells from mice with genetic ablation of the membrane guanylate cyclase A receptor for atrial natriuretic peptide (also called the atrial natriuretic peptide receptor) (GC-A KO mice) to demonstrate the involvement of this membrane receptor in the rapid E2 actions triggered in beta-cells. E2 rapidly inhibited K(ATP) channel activity and enhanced insulin release in islets from WT mice but not in islets from GC-A KO mice. In addition, DPN reduced K(ATP) channel activity in beta-cells from WT mice, but not in beta-cells from GC-A KO mice. This work unveils a new role for ERbeta as an insulinotropic molecule that may have important physiological and pharmacological implications.
No takes yet. Share an insight, caveat, or question.
Soriano et al. (2009) studied this question. 17beta-estradiol (E2) was evaluated on K(ATP) channel activity. 17beta-estradiol (1 nm) rapidly reduced K(ATP) channel activity by 60% in wild-type mouse pancreatic beta-cells, an effect involving estrogen receptor beta and the atrial natriuretic peptide receptor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: